Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 82, 2022 - Issue 2
Submit an article Journal homepage
1,134
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Effect of smoking cessation on cardiac troponin I concentrations

Eli Heggena Department of Endocrinology, Morbid Obesity and Preventive Medicine, Section for Preventive Cardiology, Oslo University Hospital, Oslo, NorwayCorrespondence[email protected]
View further author information
,
Torbjørn Omlandb Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway;c Department of Cardiology, Akershus University Hospital, Lørenskog, NorwayORCID Iconhttps://orcid.org/0000-0002-6452-0369View further author information
ORCID Icon &
Serena Tonstada Department of Endocrinology, Morbid Obesity and Preventive Medicine, Section for Preventive Cardiology, Oslo University Hospital, Oslo, NorwayView further author information
Pages 104-107 | Received 31 Aug 2021, Accepted 16 Jan 2022, Published online: 03 Feb 2022

References

  • U.S. Department of Health and Human Services. Smoking cessation: a report of the surgeon general. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020.
  • Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34(3):509–515.
  • Sze J, Mooney J, Barzi F, et al. Cardiac troponin and its relationship to cardiovascular outcomes in community Populations – A systematic review and Meta-analysis. Heart Lung Circ. 2016;25(3):217–228.
  • Omland T, de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361(26):2538–2547.
  • Kontos MC, Turlington JS. High-Sensitivity troponins in cardiovascular disease. Curr Cardiol Rep. 2020;22(5):30.
  • Lyngbakken MN, Skranes JB, de Lemos JA, et al. Impact of smoking on circulating cardiac troponin I concentrations and cardiovascular events in the general population: the HUNT study (Nord-Trondelag health study). Circulation. 2016;134(24):1962–1972.
  • Ford I, Shah AS, Zhang R, et al. High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. J Am Coll Cardiol. 2016;68(25):2719–2728.
  • Welsh P, Preiss D, Hayward C, et al. Cardiac troponin T and troponin I in the general population. Circulation. 2019;139(24):2754–2764.
  • Srivastava PK, Pradhan AD, Cook NR, et al. Impact of modifiable risk factors on B-type natriuretic peptide and cardiac troponin T concentrations. Am J Cardiol. 2016;117(3):376–381.
  • Nadruz W, Jr., Gonçalves A, Claggett B, et al. Influence of cigarette smoking on cardiac biomarkers: the atherosclerosis risk in communities (ARIC) study. Eur J Heart Fail. 2016;18(6):629–637.
  • Skranes JB, Claggett BL, Myhre PL, et al. Current smoking is associated with lower concentrations of high-sensitivity cardiac troponin T in patients with stable coronary artery disease: the PEACE trial. Circulation. 2019;140(24):2044–2046.
  • Heggen E, Svendsen M, Klemsdal TO, et al. Low carbohydrate and moderately Fat-Reduced diets similarly affected early weight gain in Varenicline-Treated overweight or obese smokers. Nicotine Tobacco Res. 2016;18(6):1440–1448.
  • Omland T, Pfeffer MA, Solomon SD, et al. PEACE investigators. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61(12):1240–1249.
  • International Federation of Clinical Chemistry and Laboratory Medicine. Committee on clinical applications of cardiac bio-markers (C-CB). [accessed October 15, 2021]. Available from: https://www.ifcc.org/ifcc-education-division/emd-committees/committee-on-clinical-applications-of-cardiac-bio-markers-c-cb/
  • Eggers KM, Lindahl B, Venge P, et al. Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly. Int J Cardiol. 2018;257:300–305.
  • Lyngbakken MN, Røsjø H, Holmen OL, et al. Temporal changes in cardiac troponin I are associated with risk of cardiovascular events in the general population: the Nord-Trøndelag health study. Clin Chem. 2019; 65(7):871–881.
  • Lyngbakken MN, Røsjø H, Hveem K, et al. Longitudinal obesity exposure over two decades is associated with subclinical myocardial injury: the Nord-Trondelag health study. Eur Heart J. 2020;41(2):ehaa946.2936.
  • Lyngbakken MN, Omland T, Nordstrand N, et al. Effect of weight loss on subclinical myocardial injury: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Prev Cardiol. 2016;23(8):874–880.
  • Heggen E, Svendsen M, Tonstad S. Smoking cessation improves cardiometabolic risk in overweight and obese subjects treated with varenicline and dietary counseling. Nutr Metab Cardiovasc Dis. 2017;27(4):335–341.
  • Aakre KM, Omland T. Physical activity, exercise and cardiac troponins: clinical implications. Prog Cardiovasc Dis. 2019;62(2):108–115.
  • Skranes J, Kleiven Ø, Aakre KM, et al. High-Sensitivity cardiac troponin I and T response following strenuous activity is attenuated by smokeless tobacco: NEEDED (North sea race endurance exercise study). J Am Heart Assoc 2020. 2014;9(19):e017363.
  • Jordan CJ, Xi ZX. Discovery and development of varenicline for smoking cessation. Expert Opin Drug Discov. 2018;13(7):671–683.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.